JP7244945B2 - 牛樟芝の酒酔い解消及び/又はアルコール代謝増加に用いる用途 - Google Patents
牛樟芝の酒酔い解消及び/又はアルコール代謝増加に用いる用途 Download PDFInfo
- Publication number
- JP7244945B2 JP7244945B2 JP2021039102A JP2021039102A JP7244945B2 JP 7244945 B2 JP7244945 B2 JP 7244945B2 JP 2021039102 A JP2021039102 A JP 2021039102A JP 2021039102 A JP2021039102 A JP 2021039102A JP 7244945 B2 JP7244945 B2 JP 7244945B2
- Authority
- JP
- Japan
- Prior art keywords
- antrodia
- water
- group
- powder
- phase solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims description 67
- 230000004060 metabolic process Effects 0.000 title claims description 19
- 241000123370 Antrodia Species 0.000 title claims description 12
- 241000723347 Cinnamomum Species 0.000 title claims description 11
- 241001486992 Taiwanofungus camphoratus Species 0.000 claims description 105
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 48
- 239000000843 powder Substances 0.000 claims description 40
- 239000004552 water soluble powder Substances 0.000 claims description 33
- 230000000694 effects Effects 0.000 claims description 27
- 239000008280 blood Substances 0.000 claims description 18
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008346 aqueous phase Substances 0.000 claims description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 10
- 101100366137 Mesembryanthemum crystallinum SODCC.1 gene Proteins 0.000 claims description 9
- 101100096142 Panax ginseng SODCC gene Proteins 0.000 claims description 9
- 101150017120 sod gene Proteins 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 6
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 6
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 230000001154 acute effect Effects 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000004530 micro-emulsion Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 235000002639 sodium chloride Nutrition 0.000 claims description 5
- 150000008163 sugars Chemical class 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 206010001605 Alcohol poisoning Diseases 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims 12
- 238000004519 manufacturing process Methods 0.000 claims 8
- 239000003925 fat Substances 0.000 claims 4
- 235000019441 ethanol Nutrition 0.000 description 65
- 241000699670 Mus sp. Species 0.000 description 47
- 241000699666 Mus <mouse, genus> Species 0.000 description 24
- 230000035987 intoxication Effects 0.000 description 23
- 231100000566 intoxication Toxicity 0.000 description 23
- 239000000243 solution Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 14
- 230000003449 preventive effect Effects 0.000 description 10
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical group C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 9
- 244000010000 Hovenia dulcis Species 0.000 description 7
- 235000008584 Hovenia dulcis Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000028527 righting reflex Effects 0.000 description 7
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 6
- 125000003158 alcohol group Chemical group 0.000 description 6
- 229960004245 silymarin Drugs 0.000 description 6
- 235000017700 silymarin Nutrition 0.000 description 6
- -1 benzeneoids Chemical class 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 201000007930 alcohol dependence Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 2
- 229920002299 Cellodextrin Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 150000004057 1,4-benzoquinones Chemical class 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000088207 Fomitopsidaceae Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000029650 alcohol withdrawal Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
Description
Claims (7)
- 酒酔い解消用牛樟芝水溶性粉末の製造方法であって、
a.牛樟芝菌糸体粉を準備する工程と、
b.前記牛樟芝菌糸体粉を超臨界二酸化炭素により抽出して濃縮したペースト状牛樟芝菌糸体超臨界抽出物と油脂を混合して牛樟芝油相溶液にする工程と、
c.水と溶質を含む水相溶液を調製し、前記溶質は水溶性塩、糖及び糖エステルで組成されたグループから選択される工程と、
d.前記牛樟芝油相溶液と前記水相溶液のマイクロエマルション化工程を行い、牛樟芝マイクロエマルション化生成物を得る工程と、
e.前記牛樟芝マイクロエマルション化生成物を凍結乾燥し、牛樟芝水溶性粉末を得る工程と、
を含む製造方法。 - 前記牛樟芝水溶性粉末は血液中のアルコール又は/及びアセトアルデヒド含有量を低減させるのに用いられる、請求項1に記載の製造方法。
- 急性アルコール中毒を治療するための牛樟芝水溶性粉末の製造方法であって、
a.牛樟芝菌糸体粉を準備する工程と、
b.前記牛樟芝菌糸体粉を超臨界二酸化炭素により抽出して濃縮したペースト状牛樟芝菌糸体超臨界抽出物と油脂を混合して牛樟芝油相溶液にする工程と、
c.水と溶質を含む水相溶液を調製し、前記溶質は水溶性塩、糖及び糖エステルで組成されたグループから選択される工程と、
d.前記牛樟芝油相溶液と前記水相溶液のマイクロエマルション化工程を行い、牛樟芝マイクロエマルション化生成物を得る工程と、
e.前記牛樟芝マイクロエマルション化生成物を凍結乾燥し、牛樟芝水溶性粉末を得る工程と、
を含む製造方法。 - 前記牛樟芝水溶性粉末は血液中のアルコール又は/及びアセトアルデヒド含有量を低減させるのに用いられる、請求項3に記載の製造方法。
- アルコール代謝を促進するための牛樟芝水溶性粉末の製造方法であって、
a.牛樟芝菌糸体粉を準備する工程と、
b.前記牛樟芝菌糸体粉を超臨界二酸化炭素により抽出して濃縮したペースト状牛樟芝菌糸体超臨界抽出物と油脂を混合して牛樟芝油相溶液にする工程と、
c.水と溶質を含む水相溶液を調製し、前記溶質は水溶性塩、糖及び糖エステルで組成されたグループから選択される工程と、
d.前記牛樟芝油相溶液と前記水相溶液のマイクロエマルション化工程を行い、牛樟芝マイクロエマルション化生成物を得る工程と、
e.前記牛樟芝マイクロエマルション化生成物を凍結乾燥し、牛樟芝水溶性粉末を得る工程と、
を含む製造方法。 - 前記牛樟芝水溶性粉末はアルコールデヒドロゲナーゼ及び/又はアセトアルデヒドデヒドロゲナーゼの活性を向上させるのに用いられる、請求項5に記載の製造方法。
- SOD酵素活性を促進するための牛樟芝水溶性粉末の製造方法であって、
a.牛樟芝菌糸体粉を準備する工程と、
b.前記牛樟芝菌糸体粉を超臨界二酸化炭素により抽出して濃縮したペースト状牛樟芝菌糸体超臨界抽出物と油脂を混合して牛樟芝油相溶液にする工程と、
c.水と溶質を含む水相溶液を調製し、前記溶質は水溶性塩、糖及び糖エステルで組成されたグループから選択される工程と、
d.前記牛樟芝油相溶液と前記水相溶液のマイクロエマルション化工程を行い、牛樟芝マイクロエマルション化生成物を得る工程と、
e.前記牛樟芝マイクロエマルション化生成物を凍結乾燥し、牛樟芝水溶性粉末を得る工程と、
を含む製造方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW109108997 | 2020-03-18 | ||
TW109108997A TWI783217B (zh) | 2020-03-18 | 2020-03-18 | 牛樟芝用於解酒及/或增加酒精代謝之用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021147394A JP2021147394A (ja) | 2021-09-27 |
JP7244945B2 true JP7244945B2 (ja) | 2023-03-23 |
Family
ID=77746464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021039102A Active JP7244945B2 (ja) | 2020-03-18 | 2021-03-11 | 牛樟芝の酒酔い解消及び/又はアルコール代謝増加に用いる用途 |
Country Status (6)
Country | Link |
---|---|
US (2) | US11759488B2 (ja) |
JP (1) | JP7244945B2 (ja) |
KR (1) | KR20210117961A (ja) |
CN (1) | CN113491720A (ja) |
AU (1) | AU2021201581A1 (ja) |
TW (1) | TWI783217B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116508991B (zh) * | 2023-05-17 | 2023-11-24 | 哈尔滨三联药业股份有限公司 | 解酒组合物及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008142588A (ja) | 2006-12-06 | 2008-06-26 | Fujifilm Corp | 水中油滴型エマルション及びその製造方法、並びに機能性粉末及びその製造方法 |
CN103893221A (zh) | 2012-12-28 | 2014-07-02 | 金颖生物科技股份有限公司 | 降低血液酒精浓度的樟芝萃取液 |
US20160257768A1 (en) | 2015-03-06 | 2016-09-08 | Ultra-Microrigin Biomedical Technology Co., Ltd. | Method of using supercritical fluid technology to separate and purify functional components of antrodia camphorata |
JP2016210770A (ja) | 2015-04-30 | 2016-12-15 | 永昌 呉 | 牛樟芝の抽出物の調製方法及びその分析方法 |
US20170281573A1 (en) | 2016-03-31 | 2017-10-05 | Pharcon Inc. | Medicinal composition for enhanced delivery of triterpenes |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103892210A (zh) * | 2013-10-31 | 2014-07-02 | 安徽倮倮米业有限公司 | 一种坚果营养米片 |
CN104027364B (zh) * | 2014-06-30 | 2017-11-03 | 深圳市仁泰生物科技有限公司 | 解酒牛樟芝含片及其制备方法 |
TWI605820B (zh) * | 2016-08-01 | 2017-11-21 | 康力生技股份有限公司 | 用以改善酒精中毒之中草藥複方組合物及其用途 |
CN108096289A (zh) * | 2017-12-28 | 2018-06-01 | 黄正明 | 一种樟芝胶囊配方及制作方法 |
CN108114267A (zh) * | 2017-12-30 | 2018-06-05 | 佛山科学技术学院 | 一种牛樟芝解酒口服液及其制备方法 |
CN108243834A (zh) * | 2018-01-03 | 2018-07-06 | 广东东阳光药业有限公司 | 牛樟芝液体培养基及其制备方法 |
JP2019149978A (ja) * | 2018-03-05 | 2019-09-12 | 株式会社I−ne | アルコール代謝促進作用を有する組成物およびそれを含有する食品 |
-
2020
- 2020-03-18 TW TW109108997A patent/TWI783217B/zh active
-
2021
- 2021-03-10 CN CN202110258567.9A patent/CN113491720A/zh active Pending
- 2021-03-11 JP JP2021039102A patent/JP7244945B2/ja active Active
- 2021-03-12 AU AU2021201581A patent/AU2021201581A1/en active Pending
- 2021-03-16 US US17/203,145 patent/US11759488B2/en active Active
- 2021-03-16 KR KR1020210034210A patent/KR20210117961A/ko not_active Application Discontinuation
-
2023
- 2023-07-24 US US18/357,668 patent/US20230364169A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008142588A (ja) | 2006-12-06 | 2008-06-26 | Fujifilm Corp | 水中油滴型エマルション及びその製造方法、並びに機能性粉末及びその製造方法 |
CN103893221A (zh) | 2012-12-28 | 2014-07-02 | 金颖生物科技股份有限公司 | 降低血液酒精浓度的樟芝萃取液 |
US20160257768A1 (en) | 2015-03-06 | 2016-09-08 | Ultra-Microrigin Biomedical Technology Co., Ltd. | Method of using supercritical fluid technology to separate and purify functional components of antrodia camphorata |
JP2016210770A (ja) | 2015-04-30 | 2016-12-15 | 永昌 呉 | 牛樟芝の抽出物の調製方法及びその分析方法 |
US20170281573A1 (en) | 2016-03-31 | 2017-10-05 | Pharcon Inc. | Medicinal composition for enhanced delivery of triterpenes |
Non-Patent Citations (1)
Title |
---|
MODERN FOOD SCIENCE & TECHNOLOGY 2018,34(7):56-60. DOI:10.13982/j.mfst.1673-9078.2018.7.009 |
Also Published As
Publication number | Publication date |
---|---|
AU2021201581A1 (en) | 2021-10-07 |
KR20210117961A (ko) | 2021-09-29 |
JP2021147394A (ja) | 2021-09-27 |
US20230364169A1 (en) | 2023-11-16 |
TW202135846A (zh) | 2021-10-01 |
US20210290709A1 (en) | 2021-09-23 |
CN113491720A (zh) | 2021-10-12 |
US11759488B2 (en) | 2023-09-19 |
TWI783217B (zh) | 2022-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101889679B (zh) | 一种具有解酒保肝作用的组合物及其在食品、保健食品中的应用 | |
KR101613693B1 (ko) | 괭생이 모자반 추출물을 유효성분으로 포함하는 아토피성 피부질환 예방 또는 치료용 조성물 및 이의 제조방법 | |
EP2057994A1 (de) | Feigenkakteen-Extraktzubereitung | |
JP2015502170A (ja) | 性的機能におけるエラジタンニンリッチな抽出物組成物 | |
JP2020511156A (ja) | 白扁豆抽出物を有効成分として含有する、二日酔いの解消及びアルコール性胃腸疾患の予防、改善または治療のための組成物 | |
WO2008156297A2 (en) | Composition for preventing or treating katzenjammer | |
US20230364169A1 (en) | Use of antrodia cinnamomea for increasing alcohol metabolism or/and hangover | |
JPH08225453A (ja) | リポプロテイン(a)低下剤及びコレステロール低下剤並びにこれを含有する医薬 | |
US20120282334A1 (en) | Process for preparing ajoene from garlic | |
TWI605820B (zh) | 用以改善酒精中毒之中草藥複方組合物及其用途 | |
KR102668450B1 (ko) | 청각 추출물 또는 이의 분획물을 유효성분으로 포함하는 숙취해소제 | |
JP7011347B2 (ja) | ベータグルカンを有効成分とする二日酔い解消用組成物またはアルコール性肝疾患の予防、改善または治療用組成物 | |
KR102151373B1 (ko) | 발효 노니를 포함하는 알러지 예방 및 개선용 식품 조성물 및 그 제조방법 | |
WO2019156213A1 (ja) | グリセロール放出促進剤 | |
KR101825104B1 (ko) | 초음파 처리를 이용하는 영지버섯 추출물의 제조방법 및 이의 용도 | |
JP2006016340A (ja) | ザクロ抽出物を有効成分とする、血中尿酸値低下剤 | |
JPH09187248A (ja) | 抗アレルギー食品 | |
TWI708610B (zh) | 油甘萃取物用於解酒、預防酒精或其代謝產物相關疾病之用途 | |
CN108720013A (zh) | 一组由果糖和茶叶提取物组成的醒酒护肝的保健食品的配方及生产工艺 | |
CN113143988B (zh) | 油甘萃取物用于解酒、预防酒精或其代谢产物相关疾病的用途 | |
BE1027552B1 (fr) | Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress | |
JP2002173434A (ja) | 抗アレルギー性組成物 | |
JPWO2007004570A1 (ja) | 持久力向上および/または抗疲労作用を有する組成物 | |
FR2709964A1 (fr) | Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès. | |
RU2361602C1 (ru) | Биологически активная добавка для профилактики и лечения вегето-сосудистой дистонии и способ ее получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210316 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220308 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220607 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220830 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230228 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230303 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7244945 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |